Remedium Capital Partners, LLC
Follow13F filer, CIK 2104501, WEST PALM BEACH, FL
Remedium Capital Partners, LLC reported $170,211,000 across 6 holdings for the quarter ended 2025-12-31, in a 13F-HR filed 2026-02-12.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0002104501-26-000004
- Period
- 2025-12-31
- Reported value
- $170M
- Holdings
- 6
- Top 10 weight
- 100%
- New
- Sold out
Holdings, Q4 2025
Share positions as resolved from 13F-HR 0002104501-26-000004, largest first. % of portfolio is the value over $170,211,000, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| SYRESPYRE THERAPEUTICS INC | 1,456,231 | $47.7M | 28.03% | Timeline | |||
| ORKAORUKA THERAPEUTICS INC | 1,552,414 | $47.1M | 27.64% | Timeline | |||
| APGEAPOGEE THERAPEUTICS INC | 583,591 | $44M | 25.88% | Timeline | |||
| JBIOJADE BIOSCIENCES INC | 1,577,750 | $24.3M | 14.3% | Timeline | |||
| CRESCENT BIOPHARMA INC.CRESCENT BIOPHARMA INC. | 361,250 | $4.28M | 2.52% | ||||
| DMRADAMORA THERAPEUTICS INC | 120,473 | $2.77M | 1.63% | Timeline |
How Q4 2025 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0002104501-26-000004 | base | 2026-02-12 | acceptance time not in the bulk data set |